Tuesday, May 10, 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK

No comments:

Post a Comment

Ugly Story Now Streaming Online: Everything You Need to Know About its Cast, Plot, and More

A psychological drama about a woman trapped in an abusive marriage who struggles to reclaim her life and freedom. from Gadgets 360 https:/...